Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan–MUC1

✍ Scribed by Vassilaros, Stamatis; Tsibanis, Anastasios; Tsikkinis, Annivas; Pietersz, Geoffrey A; McKenzie, Ian FC; Apostolopoulos, Vasso

• Book ID: 127342078
• Publisher: Future Medicine
• Year: 2013
• Tongue: English
• Weight: 758 KB
• Volume: 5
• Category: Article
• ISSN: 1750-743X
• DOI: 10.2217/imt.13.126